Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: RE: next qrt we should show 29cent ebitda

RE: next qrt we should show 29cent ebitda

posted on Jan 28, 2006 06:09AM
10/293 = .0341293
Share
New Message
Please login to post a reply